Clinical Trials Sponsored by Shanghai Kaibao Pharmaceutical CO.,LTD.

Total 4690 results

Taisho Pharmaceutical Co., Ltd.

Completed

A Phase I Study of TS-142 in Healthy Participants (Single Doses)

Healthy Volunteer

Japan
Kissei Pharmaceutical Co., Ltd.

Active, not recruiting

A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia

Uterine Fibroids (MeSH Heading: Leiomyoma)

Japan
Kissei Pharmaceutical Co., Ltd.

Active, not recruiting

A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain

Uterine Fibroids (MeSH Heading: Leiomyoma)

Japan
Qilu Pharmaceutical Co., Ltd.

Completed

Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects

Atopic Dermatitis

China
Dongkook Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of DKM420 in Patients With Osteoarthritis of Knee

Osteoarthritis of Knee

Korea, Republic of
Biotech Pharmaceutical Co., Ltd.

Completed

A Real-world Study of the Efficacy and Safety of Nimotuzumab in Combination With Chemoradiotherapy for LASCCHN (Redbull-1)

Locally Advanced Head and Neck Squamous Cell Carcinoma

China
HLB Pharmaceutical Co., Ltd.

Completed

C-Trelin Orally Disintegrated(OD) Tablet 5mg in Ataxia Due to Spinocerebellar Degeneration

Spinocerebellar Degeneration

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

Efficacy of fimaSartan on arTerIal stiFFness iN patiEntS With HypertenSion (STIFFNESS)

Hypertension

Korea, Republic of
Taisho Pharmaceutical Co., Ltd.

Completed

Clinical Study of TS-143 in Healthy Adult Male Subjects (Single-Dose Administration)

Healthy Participants

Japan
Daewoong Pharmaceutical Co. LTD.

Completed

Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3)

Dyslipidemia | Type II Diabetes

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

Fimasartan and Rosuvastatin for Hypertension and Dyslipidemia Control (FIMARO)

Cardiovascular Diseases | Hyperlipidemias

Korea, Republic of
Qilu Pharmaceutical Co., Ltd.

Completed

Bioequivalence Study of Two Olaparib Tablets in Patients With Cancers

Neoplasms

China
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1018-1 and BR1018-2 in Healthy Adult Subjects

Hypertension | Hyperlipidemia (E.G., Hypercholesterolemia)

Korea, Republic of
Qilu Pharmaceutical Co., Ltd.

Active, not recruiting

Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy in Extensive-Stage Small Cell Lung Cancer

Extensive-stage Small-cell Lung Cancer

China
Qilu Pharmaceutical Co., Ltd.

Completed

Bioequivalence Study of Montelukast Sodium Oral Thin Film and Chewable Tablet in Fasted Healthy Volunteers

Healthy Volunteers

China
Senju Pharmaceutical Co., Ltd.

Completed

Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease

Dry Eye Syndrome | Dry Eye Disease

United States
Daewoong Pharmaceutical Co. LTD.

Completed

The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis

Reflux Esophagitis

China
Taisho Pharmaceutical Co., Ltd.

Completed

A Food Effect Study of TS-142 in Healthy Subjects

Effect of Food

Japan
Qilu Pharmaceutical Co., Ltd.

Active, not recruiting

Study to Investigate the Efficacy and Safety of WX-0593 in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients

Non-small Cell Lung Cancer

China
Samjin Pharmaceutical Co., Ltd.

Completed

Clinical Study to Investigate the Efficacy of Orally Administered SA001 in Patients With Primary Sjögren's Syndrome

Primary Sjögren's Syndrome (pSS)

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Terminated

Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.

COVID-19

Indonesia
Kissei Pharmaceutical Co., Ltd.

Terminated

Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain (EDELWEISS 5)

Endometriosis

United States, Canada, Puerto Rico
Qilu Pharmaceutical Co., Ltd.

Active, not recruiting

A Phase I Study of QL1604 in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

China
Daewoong Pharmaceutical Co. LTD.

Terminated

A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2

Covid19 | SARS-COV-2 Infection

Korea, Republic of
Nihon Pharmaceutical Co., Ltd

Completed

Study of NPF-08 in Patients Who Receive Colonoscopy

Patients Who Receive Colonoscopy

Japan
Boryung Pharmaceutical Co., Ltd

Completed

A Combination Drug Including Fimasartan and Statins in Patients With Hypertension and Dyslipidemia (FIMASTAR)

Hypertension and Dyslipidemia

Korea, Republic of
Dongkook Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of a 'Graft/Prosthesis, Biomaterial (DKM410)' in the Treatment of Both Nasolabial Folds

Nasolabial Folds

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin (ENHANCE-MEXT)

T2DM (Type 2 Diabetes Mellitus)

Korea, Republic of
Taisho Pharmaceutical Co., Ltd.

Completed

Clinical Study of TS-143 in Healthy Adult Male Subjects (Multiple-Dose Administration)

Healthy Participants

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

Clinical Study on Histamine H3 Receptor Occupancy of TS-091 by PET Examination in Healthy Adult Subjects

Healthy Subjects

Japan
Boryung Pharmaceutical Co., Ltd

Completed

Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor (DETECT)

Breast Cancer | Head and Neck Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | NSCLC | Prostate Cancer

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Completed

A Study of Brexpiprazole in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
Daewoong Pharmaceutical Co. LTD.

Completed

A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers

Healthy

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Terminated

Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo

Mild to Moderate COVID-19

Korea, Republic of
SATO Pharmaceutical Co., Ltd.

Active, not recruiting

Safety and Tolerability Study of SKX-16 in Subjects With Moderate to Severe Distal Subungual Onychomycosis

Onychomycosis of Toenail

United States
Yooyoung Pharmaceutical Co., Ltd.

Active, not recruiting

Clinical Trial to Assess the Efficacy and Safety of YYC405 in Type 2 Diabetes Patients

Type 2 Diabetes

Korea, Republic of
Samjin Pharmaceutical Co., Ltd.

Completed

Clinical Study to Investigate the Systemic Exposure, Safety, and Local Tolerability of SJP002 Ophthalmic Solution in Healthy Male Volunteers

Healthy

Korea, Republic of
Samjin Pharmaceutical Co., Ltd.

Completed

Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B

Chronic Hepatitis b

Korea, Republic of
Biotech Pharmaceutical Co., Ltd.

Completed

Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer

Esophageal

China
Qilu Pharmaceutical Co., Ltd.

Active, not recruiting

A Study of the Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma

Multiple Myeloma | Recurrent or Refractory

China
Daewon Pharmaceutical Co., Ltd.

Completed

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809

Osteoarthritis | Rheumatoid Arthritis | Back Pain | Acute Upper Respiratory Tract Infection

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers.

Covid19

Korea, Republic of
Qilu Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of QL1012 in Women for Assisted Reproductive Treatment

Infertility

China
Daewoong Pharmaceutical Co. LTD.

Completed

Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects

Phase 1 Study, Healthy Volunteers

Korea, Republic of
Nihon Pharmaceutical Co., Ltd

Completed

Phase Ⅱ Dose Response Study of NPO-13 in Patients Undergoing Total Colonoscopy

Bowel Disease

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 2 Trial of Rebamipide Liquid to Determine the Effective Dose for Prevention of Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck Cancer

Head and Neck Cancer

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Pharmacodynamic Study of Cilostazol in Healthy Volunteers (CiloMecT)

Healthy

Germany
Qilu Pharmaceutical Co., Ltd.

Completed

Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD)

Healthy

China
Qilu Pharmaceutical Co., Ltd.

Completed

Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD/MAD)

Healthy

China
Otsuka Pharmaceutical Co., Ltd.

Completed

Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism

Autism

Japan

3

Subscribe